Commission clears acquisition of Hamlet Protein by Goldman Sachs and Altor
Hamlet produces soy protein used in high-end animal feed.
Altor currently has joint ownership, in partnership with Bain Capital, of EWOS, a Norwegian company active in the production and supply of fish feed and nutrition for farmed fish, primarily for salmon and trout.
But the Commission concluded the Hamlet deal would not raise competition concerns as there are no overlaps between the two feed companies' activities.
Tor Krusell, communication spokesperson at Altor, told this publication back in May the appeal of Hamlet Protein, which has production facilities in the US as well as Denmark, is the quality of its product as well as the global growth opportunities the business offers.
